We’re excited to share that the MyPal H2020 project has been awarded the ASH24 Abstract Achievement Award, which will be presented at the upcoming 66th Annual American Society of Hematology Meeting in San Diego this December!
The 66th ASH Annual Meeting and Exposition is scheduled to take place from December 7-10, 2024, in San Diego, California. This event serves as a platform for sharing groundbreaking research and developments in hematology.
The MyPal H2020 project, funded by the European Union’s Horizon 2020 program, aims to enhance palliative care for cancer patients through advanced patient-reported outcome systems.
This award acknowledges our team’s research on enhancing the quality of life for chronic lymphocytic leukemia (CLL) and myelodysplastic syndromes (MDS) patients through electronic patient-reported outcomes (ePROs).
This achievement showcases our dedication to advancing palliative care with innovative eHealth solutions. Congratulations to the entire team, and first and foremost to Thomas Chatzikonstantinou for leading this submission. Their hard work is bringing this vision to life!
Together, we’re redefining care for hematology patients, their carers, and their healthcare providers.
Useful links VIEW ABSTRACTS
Thank you to all partner organizations for this incredible journey!